• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices

Pulmonx

Pulmonx treats first patient in AeriSeal trial

February 26, 2024 By Sean Whooley

Pulmonx (Nasdaq:LUNG) announced today that it treated the first patient in a pivotal trial evaluating its AeriSeal system. The CONVERT II trial evaluates AeriSeal in limiting collateral ventilation in severe chronic obstructive pulmonary disease (COPD)/emphysema patients. Pulmonx received a staged FDA investigational device exemption (IDE) to conduct this trial late last year. Collateral ventilation occurs […]

Filed Under: Clinical Trials, Featured, Respiratory Tagged With: Pulmonx

The 18 most innovative medical devices of 2021

July 20, 2021 By Danielle Kirsh

The Galien Foundation today announced the nominees for most innovative medical devices for its 15th annual Prix Galien USA Awards. The foundation nominates devices, biotechnology and pharmaceutical products for its annual Prix Galien awards to highlight products designed to improve the human condition. “The Awards Committee is excited to introduce the nominees for the 2021 […]

Filed Under: Cardiac Implants, Cardiovascular, Catheters, Cosmetic/Aesthetic, Dental, Diagnostics, Digital Health, Endoscopic, Featured, Imaging, Implants, Optical/Ophthalmic, Pain Management, Patient Monitoring, Pharmaceutical, Replacement Heart Valves, Respiratory, Stents, Structural Heart, Structural Heart, Urology Tagged With: Allergan, baylismedical, BD, Biotronik, Boston Scientific, Cala Health, cvrx, Edwards Lifesciences, endomag, Galien Foundation, Glaukos, humanoptics, Pear Therapeutics, Prix Galien USA, Pulmonx, Sonendo, tevapharmaceuticals

Pulmonx back on track for $86M IPO

September 8, 2020 By Sean Whooley

Pulmonx last week filed a registration statement signaling its intent to raise $86 million in an IPO after withdrawing it earlier this year. Redwood City, Calif.-based Pulmonx filed the $86 million IPO in February but withdrew it in May after raising $66 million in a private financing round. Terms for pricing were not disclosed in […]

Filed Under: Business/Financial News, Funding Roundup, Initial Public Offering (IPO), Respiratory, Wall Street Beat Tagged With: Pulmonx

The 18 most innovative medical devices of 2020

July 24, 2020 By Danielle Kirsh

The Galien Foundation recently announced nominees for most innovative medical devices for its 14th Annual Prix Galien USA Awards. The foundation bestows the Prix Galien Award annually to examples of outstanding biomedical and technology products that are designed to improve the human condition. “As we celebrate 50 years of the Prix Galien process, we are honored […]

Filed Under: Cardiac Implants, Cardiovascular, Catheters, Endoscopic, Featured, Implants, Oncology, Pain Management, Patient Monitoring, Respiratory, Structural Heart, Vascular, Vision Tagged With: Abbott, BD, Biotronik, Boston Scientific, Edwards Lifesciences, endomag, Glaukos, Impulse Dynamics, Medtronic, Pear Therapeutics, Prix Galien USA, Pulmonx, Sonendo, Teva Pharmaceuticals

Pulmonx raises $66m to commercialize minimally-invasive emphysema treatment

May 5, 2020 By Sean Whooley

Pulmonx announced today that it raised $66 million in a financing round led by global life science investor Ally Bridge Group. The Redwood City, Calif.-based company also received contributions from new investors Adage Capital Management, HealthQuest Capital, Partner Fund Management and Rock Springs Capital, along with existing investors. Pulmonx secured an additional $17 million in […]

Filed Under: Business/Financial News, Funding Roundup, Respiratory Tagged With: Pulmonx

Pulmonx touts new coverage for Zephyr valve

August 28, 2019 By Sean Whooley

Pulmonx said today that its Zephyr valve designed to treat chronic respiratory disease is now covered by Priority Health under a revised lung volume reduction policy. Redwood City, Calif.-based Pulmonx’s Zephyr valves are designed to provide a less-invasive treatment option for emphysema and chronic obstructive pulmonary disease by blocking off the diseased area of the […]

Filed Under: Business/Financial News, Respiratory Tagged With: Pulmonx

The 17 most innovative medical devices of 2019

July 18, 2019 By Danielle Kirsh

The Galien Foundation recently announced nominees for most innovative medical devices for its 13th Annual Prix Galien USA Awards. The foundation awards the Prix Galien Award annually to examples of outstanding biomedical and technology product achievements that are designed to improve human condition. Nominees need to be FDA approved for market within the last five […]

Filed Under: Cardiac Implants, Cardiovascular, Drug-Device Combinations, Featured, Implants, Neuromodulation/Neurostimulation, News Well, Research & Development, Stents Tagged With: Abbott, Biotronik, Boston Scientific, Edwards Lifesciences, Endomagnetics, Glaukos, humanoptics, Lynch Biologics, Medtronic, Pear Therapeutics, Pulmonx, Sonendo, starkey, Teva Pharmaceuticals

Pulmonx raises $65m, taps Sung as CFO

May 9, 2019 By Fink Densford

Pulmonx said today that it raised $65 million in an oversubscribed equity round and added that it picked up Derrick Sung as its new chief financial officer. Funding in the round was lead by Ally Bridge Group and joined by newly invested RTW Investments, ArrowMark Partners, Driehaus Capital Management and existing investors, the Redwood City, […]

Filed Under: Business/Financial News, Featured, Respiratory, Wall Street Beat Tagged With: Pulmonx

Pulmonx wins Aetna coverage for Zephyr endobronchial valve

November 15, 2018 By Fink Densford

Pulmonx said yesterday that it won national coverage through health insurer Aetna for its Zephyr endobronchial valve system intended for treating severe emphysema and chronic obstructive pulmonary disorder. The coverage will make the Zephyr valve available to Aetna’s 22 million members, the Redwood City, Calif.-based company said. Under its new policy, Aetna specifically named the […]

Filed Under: Business/Financial News, Respiratory Tagged With: Pulmonx

Pulmonx wins FDA approval for Zephyr endobronchial valve

June 29, 2018 By Brad Perriello

The FDA today granted pre-market approval under its breakthrough devices designation to the Zephyr endobronchial valve made by Pulmonx for treating severe emphysema. Emphysema, a chronic obstructive pulmonary disease, causes irreversible damage to the lung’s alveoli, trapping air during exhalation that in turn can cause the diseased tissue to grow larger and pressure healthy lung tissue. The […]

Filed Under: Endoscopic, Food & Drug Administration (FDA), Regulatory/Compliance, Respiratory Tagged With: Pulmonx

Pulmonx touts quality of life, lung function improvements in 1-year Zephyr endobronchial valve IDE study

May 23, 2018 By Fink Densford

Pulmonx yesterday released one-year results from the pivotal trial of its Zephyr endobronchial valve designed to treat patients with severe emphysema from chronic obstructive pulmonary disease, touting significant improvements in lung function and quality of life. Results from the study were presented at the American Thoracic Society 2018 international conference and published in the American Journal […]

Filed Under: Clinical Trials, Respiratory Tagged With: Pulmonx

  • Page 1
  • Page 2
  • Go to Next Page »

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy